Wir sind mit live! Mehr erfahren

SenesTech

SNES

Börsenwert 3,51 Mio. $

0,6469 USD

-0,0523

7,48 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

0,5787

-0,0682

10,54 %

1 Tag

-7,48 %

5 Tage

-0,63 %

1 Monat

-21,21 %

3 Monate

-54,12 %

6 Monate

-60,07 %

Seit Jahresbeginn

-70,73 %

1 Jahr

-82,98 %

5 Jahre

-99,98 %

10 Jahre

-100 %

Profil: SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

Mitarbeiter: 24

Grundstoffe Spezialchemikalien

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 0 %

Neutral 100 %

Negativ 0 %

SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth

Preliminary Revenue of $1.1 Million is the Highest Quarterly Revenue in the Company's History SURPRISE, Ariz., Oct. 15, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced preliminary revenue results for the third quarter of 2026.

SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth

SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers

SURPRISE, Ariz., Sept. 23, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Evolve® family of rodent birth control products will soon be available through Grove Collaborative's online marketplace.

SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers

SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference

PHOENIX, Sept. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference

Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat

SURPRISE, Ariz., Aug. 31, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deployment of Evolve® Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts.

Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat

SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.

SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026

SURPRISE, Ariz., Aug. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026.

SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026

SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

SenesTech, Inc. (SNES) Q2 2026 Earnings Call Transcript

SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates

Revenue rose 56% sequentially and gross margin reached a company-record 73.6% in the first full quarter of in-house Amazon management, advancing the Company's intended shift to a scalable, recurring-revenue platform. SURPRISE, Ariz.

SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates

SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations

New assessment services complement existing implementation and deployment services to develop the most effective solution for each customer's rodent problem. SURPRISE, Ariz.

SenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent Infestations

SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum

Integrated e-commerce strategy drives recurring revenue while supporting long-term growth across consumer and business-to-business markets. SURPRISE, Ariz.

SenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains Momentum

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt